262 410

Cited 7 times in

Succinate-treated macrophages attenuate dextran sodium sulfate colitis in mice

DC Field Value Language
dc.contributor.author김승원-
dc.contributor.author천재희-
dc.date.accessioned2021-09-29T02:01:27Z-
dc.date.available2021-09-29T02:01:27Z-
dc.date.issued2021-07-
dc.identifier.issn1598-9100-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/184670-
dc.description.abstractThe safety and effectiveness of adalimumab was demonstrated in a phase 3 trial in Japanese patients with intestinal Behçet's disease. The aim of this study was to evaluate the long-term safety and effectiveness of adalimumab in Japanese patients with intestinal Behçet's disease.-
dc.description.statementOfResponsibilityopen-
dc.languageKorean, English-
dc.publisherTaehan Chang Yŏngu Hakhoe-
dc.relation.isPartOfINTESTINAL RESEARCH-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleSuccinate-treated macrophages attenuate dextran sodium sulfate colitis in mice-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentOthers-
dc.contributor.googleauthorI Seul Park-
dc.contributor.googleauthorMijeong Son-
dc.contributor.googleauthorHyun Woo Ma-
dc.contributor.googleauthorJihyung Kim-
dc.contributor.googleauthorDa Hye Kim-
dc.contributor.googleauthorSeung Won Kim-
dc.contributor.googleauthorJae Hee Cheon-
dc.identifier.doi10.5217/ir.2020.00075-
dc.contributor.localIdA00656-
dc.contributor.localIdA04030-
dc.relation.journalcodeJ01182-
dc.identifier.eissn1598-9100-
dc.identifier.pmid33120440-
dc.contributor.alternativeNameKim, Seung Won-
dc.contributor.affiliatedAuthor김승원-
dc.contributor.affiliatedAuthor천재희-
dc.citation.volume19-
dc.citation.number3-
dc.citation.startPage349-
dc.citation.endPage353-
dc.identifier.bibliographicCitationINTESTINAL RESEARCH, Vol.19(3) : 349-353, 2021-07-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Others (기타) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.